p.5 抽出テキスト

Recommendation Table 4 — Recommendations for computed tomography (see Evidence Table 4) ............................................................. 3983 Recommendation Table 5 — Recommendations for nuclear medicine (see Evidence Table 5) .................................................................... 3984 Recommendation Table 6 — Recommendations for endomyocardial biopsy (see Evidence Table 6) ....................................... 3985 Recommendation Table 7 — Recommendations for autopsy (see Evidence Table 7) .................................................................................................. 3986 Recommendation Table 8 — Recommendations for electro-anatomical mapping (see Evidence Table 8) ............................. 3987 Recommendation Table 9 — Recommendations for medical therapy in myocarditis (see Evidence Table 9) ........................................ 3990 Recommendation Table 10 — Recommendations for medical therapy in pericarditis (see Evidence Table 10) ....................................... 3993 Recommendation Table 11 — Recommendations for interventional techniques including circulatory support in myocarditis (see Evidence Table 11) ............................................................................................... 3993 Recommendation Table 12 — Recommendations for interventional techniques in pericarditis (see Evidence Table 12) ................................ 3994 Recommendation Table 13 — Recommendations for surgical therapy (see Evidence Table 13) .................................................................... 3995 Recommendation Table 14 — Recommendations for management of arrhythmias and prevention of sudden cardiac death in myocarditis (see Evidence Table 14) ............................................................ 3996 Recommendation Table 15 — Recommendations for risk stratification, complications, and outcomes of inflammatory myopericardial syndrome (see Evidence Table 15) ............................... 3998 Recommendation Table 16 — Recommendations for giant-cell myocarditis (see Evidence Table 16) ............................................................ 4002 Recommendation Table 17 — Recommendations for myocarditis in sarcoidosis (see Evidence Table 17) ............................................................. 4003 Recommendation Table 18 — Recommendations for immune checkpoint inhibitor-associated myocarditis (see Evidence Table 18) ................................................................................................................... 4006 Recommendation Table 19 — Recommendations for inflammatory cardiomyopathy (see Evidence Table 19) .................................................. 4007 Recommendation Table 20 — Recommendations for tuberculous pericarditis (see Evidence Table 20) ............................................................. 4008 Recommendation Table 21 — Recommendations for neoplastic pericardial involvement (see Evidence Table 21) .................................... 4009 Recommendation Table 22 — Recommendations for post-cardiac injury syndrome (see Evidence Table 22) .................................................. 4010 Recommendation Table 23 — Recommendations for purulent pericarditis (see Evidence Table 23) ............................................................. 4011 Recommendation Table 24 — Recommendations for constrictive pericarditis (see Evidence Table 24) ............................................................. 4015 Recommendation Table 25 — Recommendations for pregnancy, lactation, and reproductive issues (see Evidence Table 25) ............... 4016 Recommendation Table 26 — Recommendations for physical activity and myocarditis/pericarditis (see Evidence Table 26) ........... 4017 Recommendation Table 27 — Recommendations for multidisciplinary teams in myopericardial syndromes (see Evidence Table 27) ................................................................................................................... 4017

List of tables

Table 1 Classes of recommendations .......................................................... 3958 Table 2 Levels of evidence ................................................................................ 3959 Table 3 Terminology and stages ..................................................................... 3962 Table 4 Diagnostic criteria and classification for inflammatory myopericardial syndrome .................................................................................. 3964 Table 5 Histopathological criteria for myocarditis ................................. 3964 Table 6 Red flags for the clinical diagnosis of myocarditis and pericarditis ................................................................................................................ 3967 Table 7 Clinical risk stratification to guide work-up in inflammatory myopericardial syndrome .................................................................................. 3967 Table 8 Causes of cardiac tamponade ......................................................... 3976 Table 9 Basic and advanced level assessment ........................................... 3980 Table 10 Classification of pericardial effusion .......................................... 3982 Table 11 Parameters for reporting by endomyocardial biopsy ........ 3986 Table 12 Therapy for specific forms of myocarditis ............................. 3988 Table 13 Specific initial dosing and duration of therapy for acute and recurrent pericarditis .......................................................................................... 3991 Table 14 Tapering of corticosteroids .......................................................... 3991 Table 15 Follow-up in inflammatory myopericardial syndrome after discharge ................................................................................................................... 3998 Table 16 Indicators of non-viral aetiologies and complications (high-risk features or red flags in acute pericarditis) ............................. 3999 Table 17 Echocardiographic signs of cardiac tamponade ............................... 4013 Table 18 Definitions and therapy of main constrictive pericardial syndromes ................................................................................................................ 4014 Table 19 ‘What to do’ and ‘What not to do’ .......................................... 4020

List of figures

Figure 1 Central illustration of the ESC guidelines on myocarditis and pericarditis ................................................................................................................ 3960 Figure 2 Paradigm change in the clinical diagnosis of myocarditis ... 3961 Figure 3 Stages of inflammatory myopericardial syndrome ............... 3963 Figure 4 Diagnostic criteria by cardiovascular magnetic resonance based on the updated Lake Louise criteria ................................................ 3965 Figure 5 Diagnostic algorithm and triage for inpatient myocarditis 3968 Figure 6 Diagnostic algorithm and triage for outpatient myocarditis 3969 Figure 7 Diagnostic algorithm and triage for pericarditis .................... 3970 Figure 8 Spectrum of myocarditis presentations and outcomes ..... 3971 Figure 9 Diagnostic algorithm for acute chest pain presentation .... 3972 Figure 10 Diagnostic algorithm for acute heart failure presentation 3974 Figure 11 Diagnostic algorithm for arrhythmia presentation ............ 3975 Figure 12 Management of cardiac tamponade ......................................... 3977 Figure 13 Management of constriction ........................................................ 3978 Figure 14 The different courses of inflammatory myopericardial syndrome and the interplay between genetic background inflammation and autoimmunity beyond the initial infectious trigger 3982 Figure 15 Histopathological findings in myocarditis ............................... 3985 Figure 16 Proposed algorithm of medical therapy for pericarditis in adults (not including interventional therapies and pericardiectomy) 3992 Figure 17 Follow-up and risk stratification after acute myocarditis with arrhythmic presentation .......................................................................... 3999 Figure 18 Stages of tuberculous pericarditis ............................................. 4008 Figure 19 Triage and management of pericardial effusion .................. 4012 Figure 20 Multidisciplinary teams for inflammatory myopericardial syndrome .................................................................................................................. 4018

Abbreviations and acronyms

ACC American College of Cardiology ACS Acute coronary syndrome ADA Adenosine deaminase Downloaded from academic.oup.com/eurheartj/article/46/40/3952/8234483 by guest on 07 October 2026